Amgen Inc.
AMGN.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.54B | 8.22B | 9.37B | 9.14B | 8.77B |
| Total Other Revenue | 517.00M | 400.00M | 499.00M | 420.00M | 408.00M |
| Total Revenue | 10.05B | 8.62B | 9.87B | 9.56B | 9.18B |
| Cost of Revenue | 2.75B | 2.50B | 2.68B | 2.74B | 2.67B |
| Gross Profit | 7.30B | 6.12B | 7.19B | 6.81B | 6.51B |
| SG&A Expenses | 1.75B | 1.60B | 1.95B | 1.72B | 1.69B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 116.00M | -113.00M | 82.00M | -71.00M | 77.00M |
| Total Operating Expenses | 6.48B | 5.71B | 6.85B | 6.29B | 6.18B |
| Operating Income | 3.57B | 2.91B | 3.01B | 3.26B | 3.00B |
| Income Before Tax | 2.77B | 2.08B | 1.51B | 3.92B | 1.57B |
| Income Tax Expenses | 393.00M | 265.00M | 181.00M | 705.00M | 136.00M |
| Earnings from Continuing Operations | 2.38B | 1.82B | 1.33B | 3.22B | 1.43B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.38B | 1.82B | 1.33B | 3.22B | 1.43B |
| EBIT | 3.57B | 2.91B | 3.01B | 3.26B | 3.00B |
| EBITDA | 4.69B | 4.03B | 4.02B | 4.57B | 4.34B |
| EPS Basic | 4.40 | 3.37 | 2.47 | 5.98 | 2.66 |
| Normalized Basic EPS | 3.54 | 2.74 | 2.91 | 3.16 | 2.74 |
| EPS Diluted | 4.37 | 3.34 | 2.46 | 5.93 | 2.65 |
| Normalized Diluted EPS | 3.51 | 2.72 | 2.89 | 3.14 | 2.73 |
| Average Basic Shares Outstanding | 540.00M | 540.00M | 539.00M | 538.00M | 538.00M |
| Average Diluted Shares Outstanding | 544.00M | 544.00M | 543.00M | 542.00M | 541.00M |
| Dividend Per Share | 2.52 | 2.52 | 2.38 | 2.38 | 2.38 |
| Payout Ratio | 57.35% | 74.66% | 96.25% | 39.86% | 89.39% |